Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study of the Transition of Children From 'Artisanal' Cannabidiol to Epidiolex

NCT06924827 is registered in ClinicalTrials.gov with Elizabeth Donner as lead sponsor.

NCT NCT06924827
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06924827 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study of the Transition of Children From 'Artisanal' Cannabidiol to Epidiolex
Lead sponsor
Elizabeth Donner
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
June 30, 2029
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dravet syndrome (ds), lennox-gastaut syndrome (lgs)